Professor Bissan Al-Lazikani describes the foundations we need to support the four pillars of our new joint Research Strategy.
Liz Burtally finds out how a powerful new microscope set to arrive at the ICR will help researchers to design a new generation of drugs that target cell division.
Professor Paul Workman, CEO of The Institute of Cancer Research, reacts to his election to Fellowship of the Royal Society.
Professor Jonathon Pines, head of the Cancer Biology Division at The Institute of Cancer Research, explains what election to the Royal Society Fellowship means to him.
Dr Andrew Reynolds, Leader of the Tumour Biology team at the ICR, describes his group's research into how cancers can resist treatment by ‘stealing’ blood vessels from nearby tissues.
Dr Gabriela Kramer-Marek discusses the significance of becoming a team leader to her career, and the challenge of balancing family and work life as a boss.
Professor Louis Chesler talks about a new pilot study that will sequence 81 cancer genes in children’s tumours to help personalise cancer treatment.
Professor Andrea Sottoriva discusses how his research shows cancers evolve over time in patterns governed by the same natural laws that drive physical and chemical processes as diverse as the flow of rivers or the brightness of stars.
Professor Mel Greaves discusses highlights from his career at The Institute of Cancer Research, London, after winning the Cancer Research UK Lifetime Achievement Award